Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19

NCT: NCT04547257 · ACTIVE_NOT_RECRUITING

NCT IDNCT04547257

StatusACTIVE_NOT_RECRUITING

Start Date2021-05-04

Completion2027-06-30

Brief Summary

Safety and Effectiveness Evaluation of Seraph 100 Microbind Affinity Blood Filter (Seraph 100) in the treatment of patients with COVID-19

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑